Anti-endothelial cell antibodies in the sera of hyperprolactinemic women

Lupus

Volumn 7, Issue 6, 1998, Pages 377-382

  Krause, I ^a   Blumenfeld, Z ^b   Malchinsky, M ^a   Cohen, S ^a   Blank, M ^a   Eldor, A ^c   Weksler, B ^d   Schweitzer, K ^e   Shoenfeld, Y ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Anti cardiolipin antibodies; Anti DNA antibodies; Anti endothelial cell antibodies; Autoimmunity; Prolactin

Indexed keywords

AUTOANTIBODY; BROMOCRIPTINE; BROMOCRIPTINE MESILATE; CARDIOLIPIN ANTIBODY; CELL ANTIBODY; CELL ANTIGEN; DNA ANTIBODY; PROLACTIN; QUINOLINE DERIVATIVE;

ADULT; AGED; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CASE REPORT; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERPROLACTINEMIA; OPTICAL DENSITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERPROLACTINEMIA;

EID: 0031687376     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678920316     Document Type: Conference Paper

References (37)

1. Buskila D, Sukenik S, Shoenfeld Y. The possible role of prolactin in autoimmunity. Am J Reprod Immunol 1991; 26: 118-123.
2. Reber PM Prolactin and immunomodulation. Am J Med 1993; 95: 637-644.
3. Jara LJ et al. Prolactin, immunoregulation and autoimmune diseases. Semin Arthritis Rheum 1991; 20: 273-284
4. Lavalle C. Prolactin - a hormone with immunoregulatory properties that lead to new therapeutic approaches in rheumatic diseases. J Rheumatol 1992; 19: 893-841.
5. Walker SE. Prolactin: an immune-stimulating peptide that regulates other immune modulating hormones. Lupus 1993; 2: 67-69.
6. Nagi E, Berczi I, Friesen HG. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol 1981; 102: 351-357.
7. Lavelle C et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 1987; 14: 268-272.
8. Ferrari C et al. Thyroid autoimmunity in hyperprolactinemic disorders. Acta Endocrinol 1983; 104: 35-41.
9. Hender LP, Bynke G. Endogenous iridocyclitis relieved during treatment with bromocriptine. Am J Opthalmol 1985; 100: 618-619.
10. Blank M, Palestine A, Nussenblatt R, Slioenfeld Y. Down regulation of autoantibody levels with cyclosporin and bromocriptine in treatment of uveitis. Clin Immunol Immunopathol 1990; 54: 87-97.
11. Whyte A, Williams O. Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum 1988; 31: 927-928.
12. Blank M et al. Bromocriptime immunomodulation of experimental SLE and primary anti-phospholipid syndrome via induction of non-specific T suppressor cells. Cell Immunol 1995; 162: 114-122.
13. Buskila D et al. Autoantibody profile in the sera of women with hyperprolactinemia. J Autoimmunity 1995; 8: 415-424.
14. Meroni PL, Khamashata MA, Youinou P, Shoenfeld Y. Conference report, mosaic of anti-endothelial antibodies, review of the first international workshop on anti-endothelial antibodies: clinical and pathological significance Lupus 1995; 4: 95-99.
15. Adler Y et al. Anti-endothelial cell antibodies: a need for standardization. Lupus 1994; 3: 77-84.
16. Youinou P, Meroni PL, Khamashta MA, Shoenfeld Y. A need for standardization of anti-endothehal-cell antibody test. Immunol Today 1995; 16: 363-364.
17. Rosenbaum J et al. Measurement and characterization of circulating antiendothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988, 450-456.
18. Bodolay E et al. Cytotoxic endothelial cell antibodies in mixed connective tissue disease. Immunol Lett 1989; 20: 163-167.
19. Del Papa N et al. Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clin Immunol Immunopathol 1992; 63: 267-274.
20. Ferraro G et al. Anti-endothelial cell antibodies in patients with Wegener's granolomatosis and micropolyarteritis. Clin Exp Immunol 1990; 79: 47-53.
21. Jaffe EA, Nachman R, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745-2756.
22. Damianovich M et al. Pathogenic role of antiendothelial cell antibodies (AECA) in vasculitis: an idiotype experimental model. J Immunol 1996; 156: 4946-4951.
23. Liu ZY et al. Characterization of signal transduction pathways in human bone marrow endothelial cells. Blood 1997; 90: 2253-2259.
24. Shoenfeld Y, Schwartz RS. Immunologic and genetic factors in autoimmune disease. N Engl J Med 1984; 311: 1019-1021.
25. Cines DB, Tomaski A, Tannenbaum S. Immune endothelial cell injury in hepann associated thrombocytopenia. New Engl J Med 1987; 316: 581-589.
26. Rappaport VJ, Hirata G, Yap HK, Jordan SC. Anti vascular endothelial cell antibodies in severe pre-eclampsia. Am J Obstet Gynecol 1990; 162: 138-146.
27. Tsukada N et al. Autantibodies to each protein fraction extracted from cerebral endothelial cell membrane in the sera of patients with multiple sclerosis. J Neuroimmunol 1989; 24: 41-46
28. Stevens TR et al. Anti-endothelial cell antibodies in inflammatory bowel disease. Dig Dis Sci 1993; 38: 426-432.
29. Blann AD, Babbs C, Neuberger JM. Endothelial cell damage in primary biliary cirrhosis: influence of cholestasis and immunological mechanisms. Clin Exp Immuno 1992; 90: 88-92.
30. Wangel AG et al Anti-endothelial cell antibodies in insulin dependnet diabetes mellitus. Clin Exp Immunol 1992; 88: 410-413.
31. Ferrara N, Clapp C, Weinder R. The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 1991; 129: 896-900.
32. Clapp C, Weiner R. A specific, high affinity, saturable binding site for the 16-KD fragment of prolactin on capillary endothelial cells. Endocrinology 1992; 130: 1380-1386.
33. Wu H, Devi R, Malarkey WB. Expression and localization of prolactin messenger RNA in the human immune system Endocrinology 1996; 137: 349-353
34. Zimering MBet al. Circulating fibroblast growth factor-like autoantibodies in two patients with multiple endocrine neoplasia type 1 and prolactinoma. J Clin Endocrinol Metab 1994; 79: 1546-1552.
35. Lahat V, Miller A, Shtiller R, Touby E. Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J Neuroimmunol 1993; 47: 35-40.
36. Gutierrez MA et al. Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals. Int Arch Allergy Immuno 1996; 109: 229-235.
37. Ishibashi M, Yomaji T. Immunological abnormalities with hyperprolactinemia. Endor Soc. 71st Annu Meet 1989, p 407.